Skip to main content
Log in

Effects of compound U74500A in animal models of gastric and duodenal ulceration

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Pretreatment with U74500A (up to 0.65 mg/100 g) failed to affect gastric lesions induced by 100% EtOH gavage in Sprague-Dawley rats. Topical application of U74500A did not reduce lesions induced by 40% EtOH inex vivo gastric chamber preparations. However, pretreatment of rats with U74500A (0.65 g/100 gper os) reduced the incidence and severity of experimental duodenal ulcer induced by cysteamine HCl, and duodenal ulcer induced by cysteamine-HCl plus GABA. These results show U74500A to have powerful and specific antiduodenal ulcer actions. Pharmacologic analysis of organ-bath preparations of the small intestine show this compound to reduce intestinal contractility to applied cholinergic and serotonergic agonists. However, relaxations induced by electrical or nicotinic ganglionic stimulation were unaffected. U74500A itself caused concentrationdependent contractions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anderson DK, Braughler JM, Hall ED, Waters TR, McCall JM, Means ED: Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury. J Neurosurg 69:562–567, 1988

    Google Scholar 

  2. Hall ED, Yonkers PA, McCall JM, Braughler JM: Effects of the 21-Aminosteroid U74006F on experimental head injury in mice. J Neurosurg 68:456–461, 1988

    Google Scholar 

  3. Braughler JM, Pregenzer RL, Chase RL, Duncan LA, Jacobsen EJ, McCall JM: Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 262(22):10438–10440, 1987

    Google Scholar 

  4. Braughler JM, Hall ED, Jacobsen EJ, McCall JM, Means ED: The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs of the Future 14(2):143–152, 1989

    Google Scholar 

  5. Hall ED, Pazara KE: Effects of novel 21-aminosteroid antioxidants on postischemic neuronal degeneration.In Cerebrovascular Diseases. MD Ginsberg, WD Dietrich (eds). New York, Raven Press, 1989, pp 387–391

    Google Scholar 

  6. Braughler JM, Burton PS, Chase RL, Pregenzer JF, Jacobsen EJ, Vandoornik FJ, Tustin JM, Ayer DE, Bundy GL: Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation. Biochem Pharmacol 37(20):3853–3860, 1988

    Google Scholar 

  7. Robert A, Nezamis JE, Lancaster C, Badalamenti JN: Cysteamine-induced duodenal ulcers. A new model to test antiulcer agents. Digestion 11:199–214, 1974

    Google Scholar 

  8. Szabo S: Animal models of human disease. Duodenal ulcer disease. Animal model: Cysteamine-induced acute and chronic duodenal ulcer in the rat. Am J Pathol 93:273–276, 1978

    Google Scholar 

  9. Krantis A, Nicholson M: Augmentation of cysteamineinduced ulceration of rat duodenum by systemically administered γ-aminobutyric acid (GABA). Dig Dis Sci 34(8):1211–1216, 1989

    Google Scholar 

  10. Morris GP, Williamson TE, Hynna TT: Prostaglandins and mucosal defensive mechanisms. Can J Gastroenterol 4(3):95–107, 1990

    Google Scholar 

  11. Takeuchi K, Nishiwaki H, Okabe S: Role of local motility changes in the pathogenesis of duodenal ulcers induced by cysteamine in rats. Dig Dis Sci 32:295–304, 1987

    Google Scholar 

  12. Ohe K, Miura Y, Taoka Y, Okada Y, Miyoshi A: Cysteamine-induced inhibition of mucosal and pancreatic alkaline secretion in rat duodenum. Dig Dis Sci 33(3):330–337, 1988

    Google Scholar 

  13. McIntosh C, Bakich V, Trotter T, Kwok YN, Nichimura E, Pederson R, Brown J: Effect of cysteamine on secretion of gastrin and somatostatin from the rat stomach. Gastroenterology 86:834–838, 1984

    Google Scholar 

  14. Wallace JL, Morris GP, Krausse EJ, Greaves SE: Reduction by cytoprotective agents of ethanol-induced damage to the rat gastric mucosa: A correlated morphological and physiological study. Can J Physiol. Pharmacol 60:1686–1699, 1982

    Google Scholar 

  15. Pihan G, Regillo C, Szabo S: Free radicals and lipid peroxidation in ethanol-or aspirin-induced gastric mucosal injury. Dig Dis Sci 32:1395–1401, 1987

    Google Scholar 

  16. Walen A: Antacids and anticholinergics in the treatment of duodenal ulcer. Clin Gastroenterol 13(2):473–499, 1984

    Google Scholar 

  17. Brooks FP: The pathophysiology of peptic ulcer disease. Dig Dis Sci 30(11):15S-29S, 1985

    Google Scholar 

  18. Szabo S: Biology of disease: Pathogenesis of duodenal ulcer disease. Lab Invest 51:121–147, 1984

    Google Scholar 

  19. Tanaka H, Takeuchi K, Okabe S: Role of accumulated gastric content in the pathogenesis of cysteamine-and mepirizole-induced duodenal ulcers in the rat. J Intern Med 732 (228 suppl):69–75, 1990

    Google Scholar 

  20. Poulsen SS, Raaberg L, Therkelsen K, Skov Olsen P, Kirkegaard P: Effect of antisecretory agents and vagotomy on healing of “chronic” cysteamine-induced duodenal ulcers in rats. Dig Dis Sci 31:753–759, 1986

    Google Scholar 

  21. Tanaka H, Takeuchi K, Okabe S, Murakami M: Pathogenesis of the earliest epithelial cell damage induced by mepirizole and cysteamine in the rat duodenum. Jpn J Pharmacol 51:509–519, 1989

    Google Scholar 

  22. Tanaka H, Takeuchi K, Okabe S: The relationship of intraduodenal pH and delayed gastric emptying in duodenal ulceration induced by mepirizole or cysteamine in rats. Jpn J Pharmacol 51:483–492, 1989

    Google Scholar 

  23. Poulsen SS, Kirkegaard P, Skov Olsen P, Jensen KK, Christiansen J: Role of delayed gastric emptying in the pathogenesis of cysteamine-induced duodenal ulcer in the rat. Scand J Gastroenterol 17:325–330, 1982

    Google Scholar 

  24. Szabo S, Pihan G, Gallagher GT, Brown A: Role of local secretory and motility changes in the pathogenesis of experimental duodenal ulcer. Scand J Gastroenterol 19(suppl 92): 106–111, 1984

    Google Scholar 

  25. Groves WG, Schlosser JH, Mead FD: Acid hypersecretion and duodenal ulcers produced by cysteamine in rats. Res Commun Chem Pathol Pharmacol 9:523–534, 1974

    Google Scholar 

  26. Kirkegaard P, Poulsen SS, Loud FB, Halse C, Christiansen J: Cysteamine-induced duodenal ulcers induced and acid secretion in the rat. Scand J Gastoenterology 15:621–624, 1980

    Google Scholar 

  27. Pihan G, Kline TJ, Hollenberg NK, Szabo S: Duodenal ulceregens cysteamine and proprionitride induce gastroduodenal motility alterations in the rat. Gastroenterology 88:989–997, 1985

    Google Scholar 

  28. Takeuchi K, Nishiwaki H, Okabe S: Role of local motility changes in the pathogenesis of duodenal ulcers induced by cysteamine in rats. Dig Dis Sci 32:295–304, 1987

    Google Scholar 

  29. Livingston EH, Howard TJ, Garrick TR, Passaro EP, Jr, Guth PH: Strong gastric contractions cause mucosal ischemia. Am J Physiol 260:G524-G530, 1991

    Google Scholar 

  30. Qvist G, Dormandy J, Brown C, Slome D, Scott GBD: The experimental production of gastric ulcers by induced muscle spasm. Br J Surg 61:259–263, 1974

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krantis, A., Harding, R.K., McKay, A.E. et al. Effects of compound U74500A in animal models of gastric and duodenal ulceration. Digest Dis Sci 38, 722–729 (1993). https://doi.org/10.1007/BF01316806

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01316806

Key Words

Navigation